Aigh Capital Management 13F annual report
Aigh Capital Management is an investment fund managing more than $207 billion ran by Orin Hirschman. There are currently 39 companies in Mr. Hirschman’s portfolio. The largest investments include scPharmaceuticals Inc and Ouster Inc, together worth $31.8 billion.
$207 billion Assets Under Management (AUM)
As of 7th May 2024, Aigh Capital Management’s top holding is 3,389,159 shares of scPharmaceuticals Inc currently worth over $17 billion and making up 8.2% of the portfolio value.
Relative to the number of outstanding shares of scPharmaceuticals Inc, Aigh Capital Management owns less than approximately 0.1% of the company.
In addition, the fund holds 1,857,114 shares of Ouster Inc worth $14.7 billion.
The third-largest holding is Electrovaya Inc worth $14.4 billion and the next is Cellectar Biosciences Inc worth $11.2 billion, with 2,804,917 shares owned.
Currently, Aigh Capital Management's portfolio is worth at least $207 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Aigh Capital Management
The Aigh Capital Management office and employees reside in Baltimore, Maryland. According to the last 13-F report filed with the SEC, Orin Hirschman serves as the Managing Member at Aigh Capital Management.
Recent trades
In the most recent 13F filing, Aigh Capital Management revealed that it had opened a new position in
Humacyte Inc and bought 2,155,958 shares worth $6.71 billion.
The investment fund also strengthened its position in scPharmaceuticals Inc by buying
282,364 additional shares.
This makes their stake in scPharmaceuticals Inc total 3,389,159 shares worth $17 billion.
scPharmaceuticals Inc dropped approximately 0.1% in the past year.
On the other hand, there are companies that Aigh Capital Management is getting rid of from its portfolio.
Aigh Capital Management closed its position in Aspen Aerogels on 14th May 2024.
It sold the previously owned 1,804,484 shares for $28.5 billion.
Orin Hirschman also disclosed a decreased stake in Coya Therapeutics Inc by 0.4%.
This leaves the value of the investment at $6.44 billion and 649,427 shares.
One of the smallest hedge funds
The two most similar investment funds to Aigh Capital Management are Corundum and Gs Investments. They manage $207 billion and $207 billion respectively.
Orin Hirschman investment strategy
Aigh Capital Management’s portfolio is diversified across 3 sectors.
Currently, their heaviest sector is Health Care — making up 45.0% of
the total portfolio value.
The fund focuses on investments in the United States as
46.2% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
36% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $175 million.
The complete list of Aigh Capital Management trades based on 13F SEC filings
These positions were updated on May 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Aspen Aerogels Inc. |
Closed
1,804,484
|
$28,474,758,000 | |
| Indie Semiconductor Inc |
Closed
2,255,000
|
$18,288,050,000 | |
| scPharmaceuticals Inc |
9.09%
3,389,159
|
$17,013,578,000 | 8.21% |
| Transphorm Inc |
Closed
4,621,058
|
$16,866,862,000 | |
| Ouster Inc |
No change
1,857,114
|
$14,745,485,000 | 7.11% |
| Electrovaya Inc |
22.86%
4,119,941
|
$14,393,739,000 | 6.94% |
| Cellectar Biosciences Inc |
46.45%
2,804,917
|
$11,163,569,000 | 5.38% |
| Delcath Sys Inc |
99.61%
2,359,728
|
$11,093,406,000 | 5.35% |
| Myomo Inc |
5.03%
2,802,592
|
$9,164,476,000 | 4.42% |
| TELA Bio, Inc. |
2.71%
1,415,255
|
$8,024,496,000 | 3.87% |
| Humacyte Inc |
Opened
2,155,958
|
$6,705,029,000 | 3.23% |
| Beyond Air, Inc. |
Opened
3,714,458
|
$6,463,157,000 | 3.12% |
| Coya Therapeutics Inc |
37.07%
649,427
|
$6,442,315,000 | 3.11% |
| Fennec Pharmaceuticals Inc |
73.16%
570,332
|
$6,342,092,000 | 3.06% |
| Ideal Pwr Inc |
2,371.58%
700,000
|
$6,230,000,000 | 3.00% |
| Spruce Biosciences, Inc. |
Closed
2,123,863
|
$6,222,919,000 | |
| Eagle Pharmaceuticals Inc |
Opened
1,186,509
|
$6,217,307,000 | 3.00% |
| Theratechnologies Inc. |
0.16%
3,725,204
|
$6,156,598,000 | 2.97% |
| Liveperson Inc |
Closed
1,609,904
|
$6,101,536,000 | |
| Alimera Sciences Inc. |
31.70%
1,520,359
|
$5,929,400,000 | 2.86% |
| OneSpan Inc |
Opened
500,000
|
$5,815,000,000 | 2.80% |
| Applied Therapeutics, Inc. |
Closed
1,659,039
|
$5,557,780,000 | |
| Profound Med Corp |
No change
646,733
|
$5,516,633,000 | 2.66% |
| Infinera Corp. |
Opened
889,284
|
$5,362,383,000 | 2.59% |
| Apyx Medical Corporation |
Closed
2,040,540
|
$5,346,215,000 | |
| Intellicheck Inc |
Opened
1,514,026
|
$5,268,810,000 | 2.54% |
| Lightpath Technologies, Inc. |
5.37%
3,523,932
|
$4,863,026,000 | 2.35% |
| BK Technologies Corp |
No change
330,896
|
$4,831,082,000 | 2.33% |
| Immix Biopharma Inc |
Opened
1,555,000
|
$4,773,850,000 | 2.30% |
| Biodesix Inc |
28.72%
3,321,085
|
$4,749,151,000 | 2.29% |
| Abeona Therapeutics Inc |
Closed
787,769
|
$3,946,722,000 | |
| Red Cat Hldgs Inc |
1.22%
4,964,873
|
$3,798,128,000 | 1.83% |
| Aprea Therapeutics, Inc. |
54.39%
539,300
|
$3,504,817,000 | 1.69% |
| Cognition Therapeutics Inc |
6.94%
1,897,273
|
$3,453,037,000 | 1.67% |
| In8bio Inc |
29.85%
2,874,962
|
$3,392,456,000 | 1.64% |
| GSI Technology Inc |
Closed
944,591
|
$2,493,720,000 | |
| Veru Inc |
Closed
3,438,551
|
$2,475,757,000 | |
| Adverum Biotechnologies Inc |
Closed
3,172,819
|
$2,388,498,000 | |
| Adverum Biotechnologies Inc |
Opened
162,547
|
$2,298,407,000 | 1.11% |
| PolyPid Ltd. |
Opened
479,246
|
$2,274,653,000 | 1.10% |
| Cybin Inc |
Opened
4,651,165
|
$1,854,969,000 | 0.89% |
| Acasti Pharma Inc |
Opened
497,359
|
$1,706,549,000 | 0.82% |
| Kiora Pharmaceuticals Inc |
Opened
2,300,000
|
$1,623,800,000 | 0.78% |
| Elutia Inc |
74.32%
436,566
|
$1,375,183,000 | 0.66% |
| Brainsway Ltd. |
76.61%
242,936
|
$1,285,131,000 | 0.62% |
| Franklin Wireless Corp |
No change
390,000
|
$1,166,100,000 | 0.56% |
| Biofrontera Inc |
Opened
501,434
|
$766,203,000 | 0.37% |
| Kwesst Micro Systems Inc |
9.76%
501,915
|
$630,131,000 | 0.30% |
| Vaccinex Inc |
Closed
817,061
|
$543,182,000 | |
| Evoke Pharma Inc |
Opened
846,564
|
$516,404,000 | 0.25% |
| Vaccinex Inc |
Opened
58,365
|
$432,485,000 | 0.21% |
| Tff Pharmaceuticals Inc |
Closed
29,482
|
$206,964,000 | |
| No transactions found | |||
| Showing first 500 out of 52 holdings | |||
Hedge funds similar to Aigh Capital Management
- Epiq Capital
- Armor Investment Advisors
- Grey Street Capital
- Matisse Capital
- Axis Capital Holdings Ltd
- Saxon Interests, Inc
- Khrom Capital Management
- Corundum
- Gs Investments
- Alpha Wave Global, L.P.
- Caldwell Sutter Capital, Inc
- Empirical Asset Management
- Pcg Wealth Advisors
- Samalin Investment Counsel